Email This Article

Biopure Admits Its Blood Substitute Will Be Delayed
By Adam Feuerstein
12/07/01 - 10:31 AM EST
The biotech won't meet a year-end deadline, saying Hemopure won't go to the FDA before mid-2002.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,269.34 1,096.13 2,161.37 34.74
Oil *
77.37
UP
22.37
UP
3.12
UP
10.29
DOWN
0.08
10 Yr
3.47%
SPDR Gold
109.09
+0.22%
+0.29%
+0.48%
-0.23%
Data delayed 20 minutes

Brokerage Partners